Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster; E. Anaissie; D. Hurd; W. Bensinger; J. Mason; J. McCarty; R. Rifkin; R. Maziarz; Y. Halvorsen; V. Annino; W. Hahne

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster, E. Anaissie, D. Hurd, W. Bensinger, J. Mason, J. McCarty, R. Rifkin, R. Maziarz, Y. Halvorsen, V. Annino, W. Hahne

Knight Cancer Institute

Research output: Contribution to journal › Article

1 Scopus citations

Original language	English (US)
Pages (from-to)	58-59
Number of pages	2
Journal	Journal of Supportive Oncology
Volume	5
Issue number	4 SUPPL. 2
State	Published - Apr 1 2007

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Cite this

Schuster, M. W., Anaissie, E., Hurd, D., Bensinger, W., Mason, J., McCarty, J., Rifkin, R., Maziarz, R., Halvorsen, Y., Annino, V., & Hahne, W. (2007). Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. Journal of Supportive Oncology, 5(4 SUPPL. 2), 58-59.

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. / Schuster, M. W.; Anaissie, E.; Hurd, D.; Bensinger, W.; Mason, J.; McCarty, J.; Rifkin, R.; Maziarz, R.; Halvorsen, Y.; Annino, V.; Hahne, W.

In: Journal of Supportive Oncology, Vol. 5, No. 4 SUPPL. 2, 01.04.2007, p. 58-59.

Research output: Contribution to journal › Article

Schuster, M. W. ; Anaissie, E. ; Hurd, D. ; Bensinger, W. ; Mason, J. ; McCarty, J. ; Rifkin, R. ; Maziarz, R. ; Halvorsen, Y. ; Annino, V. ; Hahne, W. / Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. In: Journal of Supportive Oncology. 2007 ; Vol. 5, No. 4 SUPPL. 2. pp. 58-59.

@article{d7e8976a913c452abe837feffb78ac3c,

title = "Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis",

author = "Schuster, {M. W.} and E. Anaissie and D. Hurd and W. Bensinger and J. Mason and J. McCarty and R. Rifkin and R. Maziarz and Y. Halvorsen and V. Annino and W. Hahne",

year = "2007",

month = apr

day = "1",

language = "English (US)",

volume = "5",

pages = "58--59",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

publisher = "Biolink Communications, Inc.",

number = "4 SUPPL. 2",

}

TY - JOUR

T1 - Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

AU - Schuster, M. W.

AU - Anaissie, E.

AU - Hurd, D.

AU - Bensinger, W.

AU - Mason, J.

AU - McCarty, J.

AU - Rifkin, R.

AU - Maziarz, R.

AU - Halvorsen, Y.

AU - Annino, V.

AU - Hahne, W.

PY - 2007/4/1

Y1 - 2007/4/1

UR - http://www.scopus.com/inward/record.url?scp=34250652071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250652071&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34250652071

VL - 5

SP - 58

EP - 59

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

SN - 1544-6794

IS - 4 SUPPL. 2

ER -

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

ASJC Scopus subject areas

Cite this

Access to Document